NEW YORK, March 19, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s and other central nervous system
NEW YORK, March 17, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s and other central nervous system
Los Angeles, C.A. – March 16, 2015 – Since its founding in 2002, Athgo International (http://bit.ly/1x6c0n3) has been a major international force for change. Athgo offers a unique array of
NEW YORK, March 12, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system
NEW YORK, March 10, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL) a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS)
Boca Raton, FL – March 5, 2015 — Education makes for an easier life, and nobody understands that better than Patrick Donohoe, President and CEO of Paradigm Life. Donohoe speaks to
March 5, 2015 – Boca Raton, Florida — Many regard gold and silver as strong investment options to protect against inflation. Seven Star Enterprises International works to advise investors about
Kathy Hill, founder of the leading tax resolution company and best-selling author, explains why her company achieves such phenomenal success for their clients. Boca Raton, FL – March 5, 2015
NEW YORK, March 5, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system
Boca Raton, FL – March 4, 2015 – Professional services continue to thrive in a world where customers are perpetually dealing with complexity, compliance, and risk. Financial leadership is therefore
